Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Ejaculate sperm number compensation in stalk-eyed flies carrying a selfish meiotic drive element.

Meade LC, Dinneen D, Kad R, Lynch DM, Fowler K, Pomiankowski A.

Heredity (Edinb). 2019 Jun;122(6):916-926. doi: 10.1038/s41437-018-0166-y. Epub 2018 Nov 22.

PMID:
30467401
2.

Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.

Isabwe GAC, Garcia Neuer M, de Las Vecillas Sanchez L, Lynch DM, Marquis K, Castells M.

J Allergy Clin Immunol. 2018 Jul;142(1):159-170.e2. doi: 10.1016/j.jaci.2018.02.018. Epub 2018 Mar 5.

PMID:
29518427
3.

Drug-Induced Paradoxical Vocal Fold Motion.

Garcia-Neuer M, Lynch DM, Marquis K, Dowdall J, Castells M, Sloane DE.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):90-94. doi: 10.1016/j.jaip.2017.08.020. Epub 2017 Oct 14.

PMID:
29037819
4.

Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification.

Foer D, Buchheit KM, Gargiulo AR, Lynch DM, Castells M, Wickner PG.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):723-9. doi: 10.1016/j.jaip.2016.03.003. Epub 2016 Apr 16.

PMID:
27090357
5.

Melphalan desensitization following immediate hypersensitivity in a patient undergoing conditioning for autologous hematopoietic cell transplantation.

Ganetsky A, Takach PA, Lynch DM, Krause TM, Teh JS, Stadtmauer EA, Castells M, Weiss BM.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):555-6. doi: 10.1016/j.jaip.2016.01.005. Epub 2016 Feb 13. No abstract available.

PMID:
26883541
6.

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, Stablein D, Pau MG, Schuitemaker H, Sadoff JC, Billings EA, Rao M, Robb ML, Kim JH, Marovich MA, Goudsmit J, Michael NL.

Nature. 2012 Jan 4;482(7383):89-93. doi: 10.1038/nature10766.

7.

Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.

Bradley RR, Lynch DM, Iampietro MJ, Borducchi EN, Barouch DH.

J Virol. 2012 Jan;86(1):625-9. doi: 10.1128/JVI.06254-11. Epub 2011 Nov 9.

8.

Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.

Bradley RR, Maxfield LF, Lynch DM, Iampietro MJ, Borducchi EN, Barouch DH.

J Virol. 2012 Jan;86(2):1267-72. doi: 10.1128/JVI.06165-11. Epub 2011 Nov 9.

9.

Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors.

Rhee EG, Blattman JN, Kasturi SP, Kelley RP, Kaufman DR, Lynch DM, La Porte A, Simmons NL, Clark SL, Pulendran B, Greenberg PD, Barouch DH.

J Virol. 2011 Jan;85(1):315-23. doi: 10.1128/JVI.01597-10. Epub 2010 Oct 20.

10.

TLR4 ligands augment antigen-specific CD8+ T lymphocyte responses elicited by a viral vaccine vector.

Rhee EG, Kelley RP, Agarwal I, Lynch DM, La Porte A, Simmons NL, Clark SL, Barouch DH.

J Virol. 2010 Oct;84(19):10413-9. doi: 10.1128/JVI.00928-10. Epub 2010 Jul 14.

11.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Barouch DH, O'Brien KL, Simmons NL, King SL, Abbink P, Maxfield LF, Sun YH, La Porte A, Riggs AM, Lynch DM, Clark SL, Backus K, Perry JR, Seaman MS, Carville A, Mansfield KG, Szinger JJ, Fischer W, Muldoon M, Korber B.

Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.

12.

Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs.

Nkolola JP, Peng H, Settembre EC, Freeman M, Grandpre LE, Devoy C, Lynch DM, La Porte A, Simmons NL, Bradley R, Montefiori DC, Seaman MS, Chen B, Barouch DH.

J Virol. 2010 Apr;84(7):3270-9. doi: 10.1128/JVI.02252-09. Epub 2010 Jan 6.

13.

Integrating DSM-IV factors to predict violence in high-risk psychiatric patients.

Lynch DM, Noel HC.

J Forensic Sci. 2010 Jan;55(1):121-8. doi: 10.1111/j.1556-4029.2009.01197.x. Epub 2009 Oct 14.

PMID:
19840208
14.

Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.

Barouch DH, Liu J, Lynch DM, O'Brien KL, La Porte A, Simmons NL, Riggs AM, Clark S, Abbink P, Montefiori DC, Landucci G, Forthal DN, Self SG, Carville A, Mansfield K, Goudsmit J.

J Virol. 2009 Sep;83(18):9584-90. doi: 10.1128/JVI.00821-09. Epub 2009 Jun 24.

15.

Prospective study of 101 patients with suspected drink spiking.

Quigley P, Lynch DM, Little M, Murray L, Lynch AM, O'Halloran SJ.

Emerg Med Australas. 2009 Jun;21(3):222-8. doi: 10.1111/j.1742-6723.2009.01185.x.

PMID:
19527282
16.

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.

Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH.

Nature. 2009 Jan 1;457(7225):87-91. doi: 10.1038/nature07469. Epub 2008 Nov 9.

17.

Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys.

Liu J, Ewald BA, Lynch DM, Denholtz M, Abbink P, Lemckert AA, Carville A, Mansfield KG, Havenga MJ, Goudsmit J, Barouch DH.

J Virol. 2008 May;82(10):4844-52. doi: 10.1128/JVI.02616-07. Epub 2008 Mar 12.

18.

Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.

Lynch DM, Slaven T.

Clin Drug Investig. 2007;27(9):661-2. No abstract available.

PMID:
17705574
19.

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.

Abbink P, Lemckert AA, Ewald BA, Lynch DM, Denholtz M, Smits S, Holterman L, Damen I, Vogels R, Thorner AR, O'Brien KL, Carville A, Mansfield KG, Goudsmit J, Havenga MJ, Barouch DH.

J Virol. 2007 May;81(9):4654-63. Epub 2007 Feb 28.

20.

Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.

Thorner AR, Lemckert AA, Goudsmit J, Lynch DM, Ewald BA, Denholtz M, Havenga MJ, Barouch DH.

J Virol. 2006 Dec;80(24):12009-16. Epub 2006 Oct 11.

21.

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.

Liu J, Ewald BA, Lynch DM, Nanda A, Sumida SM, Barouch DH.

J Virol. 2006 Dec;80(24):11991-7. Epub 2006 Sep 27.

22.

Community senior first aid training in Western Australia: its extent and effect on knowledge and skills.

Lynch DM, Gennat HC, Celenza T, Jacobs IG, O'Brien D, Jelinek GA.

Aust N Z J Public Health. 2006 Apr;30(2):147-50.

PMID:
16681336
23.

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.

Roberts DM, Nanda A, Havenga MJ, Abbink P, Lynch DM, Ewald BA, Liu J, Thorner AR, Swanson PE, Gorgone DA, Lifton MA, Lemckert AA, Holterman L, Chen B, Dilraj A, Carville A, Mansfield KG, Goudsmit J, Barouch DH.

Nature. 2006 May 11;441(7090):239-43. Epub 2006 Apr 16.

PMID:
16625206
24.

Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.

Nanda A, Lynch DM, Goudsmit J, Lemckert AA, Ewald BA, Sumida SM, Truitt DM, Abbink P, Kishko MG, Gorgone DA, Lifton MA, Shen L, Carville A, Mansfield KG, Havenga MJ, Barouch DH.

J Virol. 2005 Nov;79(22):14161-8.

25.

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.

Lemckert AA, Sumida SM, Holterman L, Vogels R, Truitt DM, Lynch DM, Nanda A, Ewald BA, Gorgone DA, Lifton MA, Goudsmit J, Havenga MJ, Barouch DH.

J Virol. 2005 Aug;79(15):9694-701.

26.

Cranberry for prevention of urinary tract infections.

Lynch DM.

Am Fam Physician. 2004 Dec 1;70(11):2175-7. Review.

27.

Thrombolysis for acute myocardial infarction in Australasia 1999.

Mountain D, Jelinek GA, O'Brien DL, Ingarfield SL, Jacobs IG, Lynch DM.

Emerg Med (Fremantle). 2002 Sep;14(3):267-74.

PMID:
12487044
28.

Community competence in cardiopulmonary resuscitation.

Celenza T, Gennat HC, O'Brien D, Jacobs IG, Lynch DM, Jelinek GA.

Resuscitation. 2002 Nov;55(2):157-65.

PMID:
12413753
29.

Mechanical treatment of plantar fasciitis. A prospective study.

Martin JE, Hosch JC, Goforth WP, Murff RT, Lynch DM, Odom RD.

J Am Podiatr Med Assoc. 2001 Feb;91(2):55-62.

PMID:
11266478
30.

Acetylcholine-induced and nitric oxide-mediated vasodilation in burns.

Meng F, Korompai FL, Lynch DM, Yuan YS.

J Surg Res. 1998 Dec;80(2):236-42.

PMID:
9878319
31.

Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA.

Lynch DM, Rogers PE, Love JC, Salkas MJ, Skarphol KA, Gross ME, Lu MG, Petrides VH, Bruzek DJ, Cox JL, Jones KA, Kelley CA, Chan DW.

Tumour Biol. 1998;19(6):421-38.

PMID:
9817970
32.

Conservative treatment of plantar fasciitis. A prospective study.

Lynch DM, Goforth WP, Martin JE, Odom RD, Preece CK, Kotter MW.

J Am Podiatr Med Assoc. 1998 Aug;88(8):375-80.

PMID:
9735623
33.

The pressure-overloaded right ventricle in pulmonary hypertension.

Bristow MR, Zisman LS, Lowes BD, Abraham WT, Badesch DB, Groves BM, Voelkel NF, Lynch DM, Quaife RA.

Chest. 1998 Jul;114(1 Suppl):101S-106S. Review. No abstract available.

PMID:
9676654
34.

Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ.

Nature. 1997 Apr 3;386(6624):510-4.

PMID:
9087412
35.

Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus.

Davis-Poynter NJ, Lynch DM, Vally H, Shellam GR, Rawlinson WD, Barrell BG, Farrell HE.

J Virol. 1997 Feb;71(2):1521-9.

36.

Reinventing government for the clinical lab.

Lynch DM.

MLO Med Lab Obs. 1997 Jan;29(1):24-6, 28.

PMID:
10164269
37.

Training CLIA inspectors using TQM strategies.

Lynch DM.

MLO Med Lab Obs. 1995 Aug;27(8):62-4. No abstract available.

PMID:
10144938
38.

Studies on the polymorphism of the fifth component of complement in laboratory mice.

Lynch DM, Kay PH.

Exp Clin Immunogenet. 1995;12(4):253-60.

PMID:
8919358
39.

Interviewing the nonprofessional nursing employee.

Nelson EA, Lynch DM.

Nurs Manage. 1994 Oct;25(10):101-2. No abstract available.

PMID:
7970374
40.

Association of a complement allotype (C3F) with acute inflammatory responses to Candida albicans infection.

Ashman RB, Kay PH, Lynch DM, Ott K.

Med J Aust. 1994 Jun 6;160(11):732-3. No abstract available.

PMID:
8202019
41.

Studies on the structure of complement C3 and the stability of C3 derived phagocytic ligands C3b/iC3b in SJL/J and BALB/c mice.

Lynch DM, Kay PH, Papadimitriou JM, Grounds MD.

Eur J Immunogenet. 1993 Feb;20(1):1-9.

PMID:
8443150
42.

Genetic, structural, and functional studies of a C3-like protein in the marsupial Setonix brachyurus.

Lynch DM, Ashman RB, Kay PH, Papadimitriou JM.

Exp Clin Immunogenet. 1993;10(4):195-201.

PMID:
8136176
43.

Antisperm antibody binding to human acrosin: a study of patients with unexplained infertility.

Howe SE, Grider SL, Lynch DM, Fink LM.

Fertil Steril. 1991 Jun;55(6):1176-82.

PMID:
2037111
44.

Murine candidiasis: sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5.

Ashman RB, Kay PH, Lynch DM, Papadimitriou JM.

Immunol Cell Biol. 1991 Feb;69 ( Pt 1):7-10.

PMID:
1831181
45.

Bourneville's disease. A review and case report of tuberous sclerosis.

Saeva JT, Lynch DM, Guthrie JD Jr.

J Am Podiatr Med Assoc. 1988 Nov;78(11):590-2. No abstract available.

PMID:
3246659
46.
47.
48.

Platelet antibody binding in systemic lupus erythematosus.

Howe SE, Lynch DM.

J Rheumatol. 1987 Jun;14(3):482-6.

PMID:
3625630
49.

Antibody binding specificity to donor sperm in sera from infertile patients.

Lynch DM, Howe SE.

Am J Reprod Immunol Microbiol. 1987 Apr;13(4):104-7.

PMID:
2440321
50.

Painful plantar scars.

Lynch DM, Harkless LB.

J Am Podiatr Med Assoc. 1986 Dec;76(12):681-3. No abstract available.

PMID:
3543294

Supplemental Content

Loading ...
Support Center